Neoepitope yeast vaccine (NantBioScience)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNeoepitope yeast vaccine (NantBioScience)
Drug Alias NameNeoepitope yeast vaccine - NantBioScienceYE-NEO-001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsLiver Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNantbioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesNantbioscience Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsLiver Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A